Restoring consciousness with ultrasonic deep brain stimulation during anesthesia
Official title: Restoration of Consciousness With Ultrasonic Deep Brain Stimulation During Anesthetic Sedation
Run by University of Michigan · NCT07221539 · Data updated 2026-11-12
We will try low-intensity focused ultrasound during MRI in healthy adults sedated with propofol or dexmedetomidine to see if it speeds return of consciousness.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 40 Years |
| Sex | All |
| Enrollment | 168 (estimated) |
| Sponsor | University of Michigan Academic / other |
| Locations | 1 site (Ann Arbor, Michigan) |
| Status | Recruiting |
| Started | October 24, 2025 |
| Main results expected | July 30, 2027 |
| Study ends | July 30, 2027 |
| Registry record updated | October 15, 2026 |
| Trial ID | NCT07221539 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are healthy, English-speaking, right-handed adults with ASA physical status I and BMI below 30 who can safely undergo MRI and receive standard sedative medications.
✕Probably not a fit
People with neurological, cardiovascular, or pulmonary illness, significant head injury, BMI over 30, pregnancy or breastfeeding, MRI contraindications, or allergies to the study drugs are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Healthy, right-handed adults with BMI under 30 will receive controlled sedation with either propofol or dexmedetomidine while undergoing functional MRI. Low-intensity focused ultrasound pulsation (LIFUP) will be targeted to brain regions including the dorsolateral prefrontal cortex, anterior insula, and central thalamus while multiple fMRI images are acquired. The device has been designated non-significant risk by the FDA, and the protocol focuses on the ultrasonic stimulation and imaging rather than testing the sedative drugs. The study aims to map mental-function-related brain activity across sedation depths and determine whether ultrasonic stimulation changes the timing of return to consciousness.
Why it matters
Potential benefit: If successful, this approach could shorten or accelerate recovery of consciousness after sedation and inform new treatments for disorders of consciousness.
How similar studies have gone: Early animal and small human studies show ultrasound can modulate brain activity, but using focused ultrasound to restore consciousness during anesthesia is largely novel and not yet proven.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Healthy study participants with American Society of Anesthesiologists (ASA) Physical Status Classification System-1 status * The participants will be right-handed adults * Body mass index (BMI) less than 30. * All subjects will be English speakers. Exclusion Criteria: * Medical contraindication to MRI scanning; are unable to undergo MRI scanning because of possible pregnancy or currently breastfeeding, * BMI\>30, * metallic substances in the body, claustrophobia, anxiety, or cardiopulmonary disease; or have an intracranial structural abnormality on T1-weighted MRI scans. * History of allergy to propofol, dexmedetomidine, any components of propofol or dexmedetomidine, eggs or egg products, soybean or soybean products, * Neurological, cardiovascular, or pulmonary illness; * Significant head injury with loss of consciousness; * Learning disability or other developmental disorder; sleep apnea or any severe snoring history; gastroesophageal reflux disease (GERD) or heartburn; pancreatitis or a history of pancreatitis, or sensory/motor loss sufficient to interfere with performance of the study; epilepsy/seizure disorder (including a history of seizures) or stroke (including a history of stroke). * Participants with tattoos in the head or neck region will be excluded from study; other tattoos are subject to determination by investigators based on their assessment regarding participant safety. * Recent food or liquid intake (within 8 hours). * History of drug use, have a positive drug screen, are unwilling to abstain from alcohol for 24 hours prior to dosing, or have a current history of nicotine use. -----Negative pregnancy test result, if applicable. * Potential participants who have participated in a clinical trial using an investigational drug or device within 30 days will be considered for enrollment after 30 days.
Where it's running
-
University of Michigan
Ann Arbor, Michigan, United States Recruiting
Study contacts
- Principal investigator: Zirui Huang — University of Michigan
- Study coordinator: Aaron Ellis
- Email: aaronel@med.umich.edu
- Phone: 734-647-8129
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Tributyrin for PSP: a virtual, early-phase study
This study tests whether tributyrin is safe and tolerable in people with Progressive Supranuclear Palsy who are 45 or older, using virtual visits.
-
Powered vs Manual Toothbrushes for Kids: Does it affect Cavity Risk?
This study tests whether using a powered toothbrush twice daily for a year lowers cavity risk in kids aged 8–12 compared with a standard manual brush, using fluoride toothpaste as the control.
-
PIONEER-Prognosis: Using biomarkers and wearables to forecast recovery after mild traumatic brain injury
This study tests whether blood biomarkers, health data from records, and wearables can help predict how people recover after a mild traumatic brain injury treated in the emergency department.
-
Sex hormones, menopause, and exercise in aging women
This study tests how hormonal status and resistance training affect age-related muscle and nerve function in postmenopausal women.
-
RENEW: a digital program to help people with axial spondyloarthritis manage energy and symptoms
A web-based, peer-led program called RENEW is tested to see if people with axial spondyloarthritis can easily use it, like it, and benefit from it in managing fatigue and symptoms.
-
Biomarkers plus guidelines to reduce unnecessary brain CTs after head injury
This trial tests whether adding GFAP and UCH-L1 biomarker results to standard guidelines can safely reduce head CT scans in adults with suspected traumatic brain injury who come to the emergency department.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.